THYMOCYTE IMMUNE GLOBULIN NOS for Transplant rejection: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 173 adverse event reports in the FDA FAERS database where THYMOCYTE IMMUNE GLOBULIN NOS was used for Transplant rejection.

Most Reported Side Effects for THYMOCYTE IMMUNE GLOBULIN NOS

Side Effect	Reports	%	Deaths	Hosp.
Off label use	749	13.5%	242	300
Drug ineffective	692	12.5%	226	245
Cytomegalovirus infection	404	7.3%	127	126
Product use in unapproved indication	396	7.1%	122	86
Transplant rejection	340	6.1%	22	68
Post transplant lymphoproliferative disorder	319	5.7%	182	103
Epstein-barr virus infection	255	4.6%	126	58
Pneumonia	254	4.6%	104	104
Multiple organ dysfunction syndrome	250	4.5%	227	119
Coma	247	4.4%	19	231
Pneumonia aspiration	239	4.3%	0	220
Somnolence	235	4.2%	6	223
Cytomegalovirus viraemia	228	4.1%	33	73
Gastrooesophageal reflux disease	227	4.1%	0	216
Pyrexia	224	4.0%	62	137